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EVIDENCE-BASED MEDICINE METHODOLOGY –
SYSTEMATIC REVIEWS AND META-ANALYSES
W. Zhang
Nottingham University, Nottingham, United Kingdom
Meta-analysis was ﬁrst proposed by Glass (1976). The term
meta-analysis refers to the statistical methods to systematically
combine the outcomes of a series of different experiments or
investigations. Over 30 years of application and development,
meta-analysis has been established as a useful method in sum-
marizing research evidence for clinical decision-making. Con-
sequently, it becomes a major foundation for Evidence-Based
Medicine. Meta-analysis is also referred as quantitative review
(Greenland 1987) or systematic review (Peto 1987). The latter
denotes a full range of systematic assessment of clinical evi-
dence, not necessarily including statistical synthesis of evidence.
The contribution of meta-analysis in the management of os-
teoarthritis is apparent, from the conﬁrmation of the treatment
effects for exercise (Roddy 2005), to the comparative effective-
ness between acetaminophen and NSAIDs (Zhang 2004), as
well as the gastrointestinal toxicity of NSAIDs (Ofman 2002) and
more recently the cardiovascular side effects of rofecoxib (Juni
2004). It also raises questions such as whether topical NSAIDs
only work for OA in short-term period (Lin 2004), and whether
vascular side effects are the class effects of COX-2 inhibitors or
NSAIDs (Kearney 2006).
Whilst the merits of meta-analysis are recognized, it has some
pitfalls including publication bias and problems with heterogene-
ity. It is debated, for example, whether an overall pooling of
effect sizes of glucosamine from different trials irrespective of
quality would be adequate (Towheed 2005). Nevertheless, like
many other developments, meta-analysis continues to evolve
and contribute to the ﬁeld. It has become a major tool in the
development of treatment guidelines (Zhang 2005, 2007) and
has been extended to answer other clinical questions such as
diagnosis (Zhang 2006).
References will be provided upon request.
ANGIOGENESIS IN OA
D.A. Walsh
University of Nottingham, Academic Rheumatology, Nottingham,
United Kingdom
Purpose: To explain the relevance of inﬂammatory blood vessel
growth in OA
Methods: Synthesis of recent and historical data
Results: During OA, new blood vessels grow in synovium, at the
osteochondral junction and in osteophytes. Neovascularisation
can facilitate inﬂammation, degrade cartilage matrix, and lead to
new bone formation and sensory nerve growth. Different factors
appear to drive neovascularisation in different joint structures.
Inﬂammation, both in the synovium and within the subchondral
bone, stimulates angiogenesis by tipping the balance between
angiogenic and anti-angiogenic factors.
Conclusions: Addressing angiogenesis and the factors that
drive it, offers the potential to modify both symptoms and struc-
tural progression in OA.
CHEMOKINES IN OA
A. Facchini
Istituti Ortopedici Rizzoli, University of Bologna, Bologna, Italy
Purpose: Chemokines represent a large family of small
molecules with conserved structural motifs which act on 7 trans-
membrane receptors. The aim of our work was to investigate
on the major effects mediated by these molecules on cartilage,
bone and synovium in Osteoarthritis.
Methods: Primary human chondrocytes and osteoblasts and
full thickness cartilage or bone samples were obtained from
OA patients undergoing joint arthroplasty. High density or three
dimensional or organ culture, RNA (real time PCR and microar-
ray) and protein (immunohistochemistry, ELISA or ﬂuorescence
bead-based multiplex assays) expression analysis, enzyme ac-
tivity assays, primary human monocytes chemotaxis assays and
functional genomic analysis were employed in our studies.
Results: Some chemokines are constitutively expressed in nor-
mal chondrocytes and strongly unregulated in OA (Borzi RM et
al, FEBS Lett 1999; 455:238). The analysis of the distribution
of the chemokine receptors indicates their expression in the
middle lower layers of the tissue. Chemokine activation is able
to induce DNA synthesis and gene expression and release of
MMPs (MMP-1, MMP-3 and MMP-13) and of other enzymes with
key roles in ECM breakdown, such as NAG, cathepsin B and
aggrecanases (Borzi RM et al, Arthritis Rheum 2000;43:1734;
Mazzetti I et al, Arthritis Rheum 2004;50:112).GROα/CXCL1 in-
duces chondrocyte apoptosis in chondrocytes cultured in vitro or
in the context of their native ECM (Borzi RM et al, Arthritis Rheum
2002;46:3201).This feature is in keeping with the ability reported
for GROα/CXCL1 and IL-8/CXCL8 to promote chondrocyte hy-
pertrophy thus pushing the chondrocytes beyond the status of
“maturational arrest” in chondrogenesis, kept in normal healthy
cartilage. Noteworthy, GROα/CXCL1 induced chondrocyte hy-
pertrophy requires a co-receptor role of chondroitin-sulphate and
is inhibited by soluble CS possibly via a scavenging activity
(Olivotto E et al, J Cell Physiol 2007; 210: 417).
Chemokines can also affect the underlying bone contributing to
the thickening which takes place in OA. IP-10/CXCL10 and BCA-
1/CXCL13 up regulates gene expression of alkaline phosphatase
and collagen type I and also alkaline phosphatase activity (Lisig-
noli G et al, J Cell Physiol 2006; 206:78-85) in osteoblasts derived
from OA patients. With regards to chemokine effects on the syn-
ovium, chemokines may likely contribute to the recruitment of
inﬂammatory cells into the synovial membrane and into the syn-
ovial ﬂuid. Recent experiments with primary human monocytes
(previously shown to be the prevalent cell type in OA synovial
ﬂuid) revealed that MCP-1 is the chemokine most closely asso-
ciated with in vitro chemotaxis, and that it is dependent on both
NF-κB activating kinases.
Conclusions: Chemokines contribute to cartilage pathophys-
iology through autocrine and paracrine loops and medi-
ate a crosstalk among the joint compartments. Since many
chemokines are produced by normal chondrocytes, a detailed
gene expression analysis of chemokines and receptors in nor-
mal and OA cartilage as well as in chondrocyte differentiation
or endochondral ossiﬁcation could help to distinguish members
of this family with physiological functions from chemokines that
deserve to be targeted for therapeutic intervention.
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EVOLVING INDICATIONS FOR JOINT REPLACEMENT
SURGERY IN OA: HIP, KNEE AND ANKLE
V. Goldberg
Case Western Reserve University, Cleveland, OH
Purpose: Total joint arthroplasty has become a reproducible
surgical treatment for osteoarthritis with excellent outcomes. In
2003 approximately 418,000 total knee replacements and over
220,000 hip replacements were performed in the U.S. and this
number is increasing at a rate of 11% for knee replacement and
2.5% for hip replacement per year. During the last decade the
indications for both of these procedures has widened.
Methods: Previously younger and very elderly patients with
OA were discouraged from having total hip or knee replace-
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ment because of the increased incidence of failures in those
patients. The primary reasons for the failures observed were
wear, loosening and mechanical failures. Recent advances in
designs, materials, surgical technique and instrumentation has
dramatically improved these procedures. For example, alterna-
tive bearing surfaces such as highly crossed linked polyethylene
and enhanced ﬁxation methods using improved porous surfaced
implants have signiﬁcantly reduced wear, bone loss from osteoly-
sis and implant loosening. Minimally invasive surgical procedures
have accelerated the rehabilitation of patients and sophisticated
instrumentation provides excellent restoration of anatomy.
Results: Using these contemporary design materials and sur-
gical techniques implant survival rates of 98-99% at ten years
and 90-95% at 15-20 years can be expected following total hip
or knee replacement even in younger, active patients. By con-
trast, total ankle replacement was until recently a procedure of
historical interest because of the high rate of loosening and
mechanical failure. Early results of total ankle replacement with
contemporary designs have been encouraging, but current rec-
ommendations are for the procedure to be performed for low
demand patients by surgeons who have completed special train-
ing for the technique.
Conclusions: Future improvement in designs and materials of
joint replacements will continue to enhance patient outcomes
and functional long-term implant survival.
SHOULDER ARTHROPLASTY FOR ARTHRITIS –
SURFACE, STEMMED OR REVERSE
M. Thomas
Heatherwood and Wexham Park Hospitals, Windsor, Berkshire,
United Kingdom
Shoulder replacement using an ivory prosthesis was ﬁrst
recorded in 1890 by a Romanian surgeon Theristocles Gluck
who was born in 1853. However, Emile Pean is more widely
recognized for a shoulder replacement, made of rubber and plat-
inum, he performed in Paris in 1893 to treat the late effects of
tuberculosis.
Despite these early pioneering operations it was not until
the 1950s that signiﬁcant advances were made in shoulder
arthroplasty, which is currently used today in the treatment
of osteoarthritis, rheumatoid arthritis, cuff tear arthropathy, os-
teonecrosis, instability arthritis and post infective arthropathy.
In Europe in the 1950s tumour prostheses were developed to
replace the resected proximal humerus, but as the rotator cuff
was usually sacriﬁced during these procedures this resulted in
anterosuperior subluxation of the implant. Constrained joints like
hip replacements were therefore developed to stabilize the artic-
ulation, but these lateralized the centre of rotation of the shoulder
resulting in early loosening. Reversing the ball and socket ge-
ometry, i.e. with the ball on the glenoid and the socket on the
humerus, was attempted in a variety of designs, but all failed
because the centre of rotation remained lateral to the scapula.
This resulted in limitation of movement and considerable torque
being transmitted to the glenoid component causing loosening.
In the 1970s Paul Grammont redesigned the reverse geometry
prosthesis (Delta) for the use in cuff arthropathy. He used a large
glenoid hemisphere with no neck and a socket on the humeral
side which inclined almost horizontally and covered less than half
of the hemisphere. This design medialises the centre of rotation
and therefore minimises the torque transmitted to the glenoid
component. This implant allows, in the absence of the cuff, the
anterior and posterior deltoid ﬁbres to act as abductors of the
shoulder. It also restores the tension in the deltoid by lowering the
humerus with respect to the acromion, thus allowing the deltoid
to function without the rotator cuff. Although this can therefore
restore active elevation rotation still remains limited. The results
of this implant in the treatment of rotator cuff arthropathy are a
signiﬁcant improvement on the alternatives available at 5 - 10
years although it is still recommended for older patients (over
70 years) with low functional demands. It has also been used in
rheumatoid arthritis, where cuff function is often poor, in revision
surgery, in tumour surgery and to treat difﬁcult proximal humeral
fractures, all of which have far less predictable results.
Charles Neer working in the 1950s in New York developed
proximal humeral head prosthesis for the management of frac-
tures, but later in 1972 developed a glenoid component so that
glenohumeral arthritis could be treated by total shoulder replace-
ment. The Neer humeral prosthesis was a cemented monoblock
design, but as with hip arthroplasty modular designs were de-
veloped to allow various stem/head combinations to be used.
In the 1990s, with the recognition of the anatomical variation
of the proximal humerus, particularly with respect of offset and
version of the humeral head to the humeral shaft, third gen-
eration modular prostheses have been developed. These allow
the surgeon to replicate the patients’ proximal humeral anatomy
using these stemmed implants which were also developed in
uncemented forms. There are now many papers reporting the
results of stemmed total shoulder and hemiarthroplasties in the
treatment of both inﬂammatory and degenerative disease.
Surface replacement of the humeral head was developed ini-
tially in the late 1970s both in cemented and uncemented forms.
These types of implants can be used in glenohumeral arthritis in-
cluding osteonecrosis providing there is sufﬁcient humeral head
remaining - about 60% of normal is required. Such implants have
advantages over stemmed prostheses whilst reported results for
osteoarthritis, rheumatoid arthritis and osteonecrosis are cer-
tainly equivalent. Humeral implants can be reliably centered on
the patients’ humeral head and therefore negate the problems
of variable inclination, version and posterior offset. Surface re-
placement requires minimal bone resection which is particularly
important in the younger patient. Stems produce a stress riser
at the tip of the prosthesis which may result in periprostheic
fracture. 30% of unsatisfactory results post stemmed shoulder
replacements are due to component malalignment, which could
be prevented by the use of surface arthroplasty. Revision surgery
for component malposition or for infection is very difﬁcult both
when the stem is cemented and uncemented as stem extraction
can be very destructive to the proximal humerus. If complica-
tions occur requiring revision then certainly revising a surface
replacement is much less demanding.
One of the most debated topics in shoulder surgery is whether to
do a hemiarthroplasty or total replacement. There are advocates
for both. With stemmed implants there seems to be an advantage
in osteoarthritis for total replacement as the early pain relief
and function is improved and the revision rate from hemi to
total for glenoid erosion exceeds the rate of glenoid component
revision. This is not true in surface replacement where results of
hemi and total are comparable in osteoarthritis and rheumatoid.
The rationale for a hemiarthroplasty is to avoid the insertion
of polyethylene, which if worn produces debris which in turn
causes the eventual loosening and failure of the joint. This is
also the reported cause of failure in the reversed geometry Delta
prosthesis where impingement of the humeral component on the
scapula neck produces notching and wear of the polyethylene.
The problem of polyethylene debris has led some to recommend
drilling the glenoid surface to encourage ﬁbrocartilage formation
and others to use biolological resurfacing.
In conclusion there is now a choice of prostheses designed to
manage particular pathologies. A stemmed prosthesis is required
for fracture reconstruction as it was initially designed. A reverse
prosthesis in cuff arthropathy, for which it was designed, will in
an elderly individual achieve a better functional result than the
alternative stemmed or surface implant. When the pathology is
conﬁned to the articular surface it would therefore appear rational
to use a surface replacement as it was speciﬁcally designed for
the use in arthritis. The problem of the glenoid and potential
